Kuros Biosciences’ Post

𝗧𝗵𝗲 𝗲𝘃𝗶𝗱𝗲𝗻𝗰𝗲 𝗯𝗲𝗵𝗶𝗻𝗱 𝗠𝗮𝗴𝗻𝗲𝘁𝗢𝘀™ 𝗶𝘀 𝗴𝗿𝗼𝘄𝗶𝗻𝗴... In the latest independent Level 1 human clinical study 𝗽𝘂𝗯𝗹𝗶𝘀𝗵𝗲𝗱 𝗶𝗻 𝙎𝙥𝙞𝙣𝙚, MagnetOsᵀᴹ achieved significantly higher fusion rates compared to autograft. ¹ In comparison to a previous investigator-initiated study with the same design protocol, one-year fusion rates for MagnetOs were far higher than the previous study for Attrax®. ¹˒² • 𝟳𝟵% 𝗠𝗮𝗴𝗻𝗲𝘁𝗢𝘀 𝗣𝗟𝗙 𝗳𝘂𝘀𝗶𝗼𝗻 𝗿𝗮𝘁𝗲 (𝟮𝟬𝟮𝟰). • 𝟱𝟱% 𝗔𝘁𝘁𝗿𝗮𝘅 𝗣𝗟𝗙 𝗳𝘂𝘀𝗶𝗼𝗻 𝗿𝗮𝘁𝗲 (𝟮𝟬𝟮𝟬). Visit our Evidence Center to learn more about the details of this Level 1 trial – and what it means for you → https://lnkd.in/e5K7XtsM #KurosBiosciences #MagnetOs #Level1Data #GrowBoneMagnetOs #NeedleGrip

To view or add a comment, sign in

Explore topics